08:48 AM EDT, 08/08/2024 (MT Newswires) -- GoodRx ( GDRX ) reported Q2 adjusted earnings Thursday of $0.08 per diluted share, compared with $0.07 a year earlier.

Analysts surveyed by Capital IQ expected $0.09.

Revenue for the quarter ended June 30 was $200.6 million, compared with $189.7 million year earlier. Analysts surveyed by Capital IQ expected $200.4 million.

The company said it expects Q3 revenue of approximately $193 million to $197 million. Analysts surveyed by Capital IQ expect $202.5 million.

For the full-year 2024, the company said it now expects revenue at low end of its previous $800 million to $810 million guidance range.

Shares of GoodRx ( GDRX ) were falling more than 10% in recent premarket activity.

Price: 7.70, Change: -0.91, Percent Change: -10.57